Wanbury Limited (BOM:524212)
224.00
-1.35 (-0.60%)
At close: Sep 25, 2026
Wanbury Employees
Wanbury had 1,200 employees as of March 31, 2026. The number of employees decreased by 182 or -13.17% compared to the previous year.
Employees
1,200
Change (1Y)
-182
Growth (1Y)
-13.17%
Revenue / Employee
5.44M INR
Profits / Employee
465.73K INR
Market Cap
7.83B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 1,200 | -182 | -13.17% |
| Mar 31, 2025 | 1,382 | -109 | -7.31% |
| Mar 31, 2024 | 1,491 | -91 | -5.75% |
| Mar 31, 2023 | 1,582 | 198 | 14.31% |
| Mar 31, 2022 | 1,384 | 228 | 19.72% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Albert David | 1,476 |
| Lincoln Pharmaceuticals | 1,352 |
| Kopran | 1,156 |
| ZIM Laboratories | 632 |
| Fermenta Biotech | 630 |
| Medicamen Biotech | 405 |
| Bharat Parenterals | 404 |
| Anuh Pharma | 323 |
Wanbury News
- 3 months ago - Wanbury successfully clears TGA inspection at Tanuku API facility - Business Upturn
- 8 months ago - Wanbury begins commercial production of high-potent anaesthetic API - Business Upturn
- 11 months ago - Wanbury implements SAP S/4HANA ERP to drive future ready operations - Business Upturn
- 1 year ago - Wanbury launches next-gen iron supplement ‘C RED’ to revolutionize anemia management in India - Business Upturn
- 1 year ago - Wanbury receives GMP certification from ANVISA for Patalganga facility - Business Upturn
- 1 year ago - Wanbury’s Tanuku facility in Andhra Pradesh completes ANVISA inspection with zero observations - Business Upturn
- 1 year ago - Wanbury launches Wanbury C-RED and Ketamine Hydrochloride - Business Upturn
- 1 year ago - Wanbury shares rise 2.56% following company refinances Rs 95 crore NCDs, reducing interest costs - Business Upturn